Results 271 to 280 of about 674,291 (325)

Studies on Roentgenologic Appearance in Pulmonary Hypertension : Relationship between the Appearance of Pulmonary Vasculature on the Roenrgenologic Chest Film and Pulmonary Hemodynamics

, 1962
Eiichi Miyake
openalex   +2 more sources

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Outcomes monitoring in pulmonary endarterectomy: Paving the road to success

Revista Portuguesa de Cardiologia, 2021
Maria José Loureiro
doaj  

Editorial: Pulmonary hypertension in atrial septal defect. [PDF]

Front Cardiovasc Med
Krishnathasan K, Rafiq I, Dimopoulos K.
europepmc   +1 more source

Pulmonary Pulmonary Hypertension

, 1965
Junichi Mise
openalex   +2 more sources

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Pulmonary hypertension in pregnancy: two sides to a coin. [PDF]

Singapore Med J
Ong JYS, Yap JJY, Dashraath P, Low TT, Choolani M, Poh KK.   +5 more
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Pulmonary hypertension associated with COPD: a phenotype analysis. [PDF]

ERJ Open Res
Steger M, Canuet M, Martin G, Labani A, Schwartz JC, Enache I, Schuller A, Meyer L, Chaouat A, Kessler R, Montani D, Riou M.   +11 more
europepmc   +1 more source